Invention Grant
- Patent Title: Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
-
Application No.: US16383889Application Date: 2019-04-15
-
Publication No.: US10954268B2Publication Date: 2021-03-23
- Inventor: Louis Anthony Tartaglia , Bart Henderson , Leonardus H. T. Van Der Ploeg
- Applicant: RHYTHM PHARMACEUTICALS, INC.
- Applicant Address: US MA Boston
- Assignee: RHYTHM PHARMACEUTICALS, INC.
- Current Assignee: RHYTHM PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Boston
- Agency: Lando & Anastasi, LLP
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/08 ; A61K38/08 ; C07K14/68 ; C07K14/72 ; C07K7/06
Abstract:
A method of treating a disorder in a subject. The method comprises administering to said subject an effective amount of an agonist of the melanocortin-4 receptor (MC4R). The subject is a heterozygous carrier of an MC4R mutation, and the disorder results from an attenuated response of MC4R to α-melanocortin stimulating hormone (α-MSH).
Public/Granted literature
- US20200017546A1 METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS Public/Granted day:2020-01-16
Information query
IPC分类:
